About this Research Topic
Gluten-related disorders are heterogeneous conditions and thus require a multidisciplinary approach for a better understanding and management. The absence of a conclusive diagnosis often results in decreased adherence to GFD, which can negatively affect the health of those who truly suffer from gluten-related disorders. Novel insights into pathomechanisms, novel biomarkers, and additional therapeutic strategies are urgently needed to detect a pathological response more efficiently to gluten to improve clinical diagnosis and management of these diseases. Therefore, this Research Topic aims to provide new insights into the pathogenesis, diagnosis, and management of gluten-related disorders.
Topics to be covered within this Research Topic are (but are not limited to):
• Advances in diagnostic tools and monitoring of gluten-related disorders.
• Dietary management and patterns in a gluten-free diet: technological and nutritional aspects.
• Dietary interventions in Celiac Disease and Non-celiac gluten sensitivity.
• Epidemiology and new biomarkers in Celiac Disease, Gluten and Non-gluten intolerance and sensitivities.
• Preventive strategies and alternative therapies for gluten-related disorders.
• Role of microbiota and its related metabolites in Celiac Disease and, Gluten and Non-gluten intolerance and sensitivities.
• Environmental factors (microbial agents, dietary components or patterns, breastfeeding, etc.) associated with gluten-related disorders.
We welcome proposals ranging from original research to review articles to contribute to a deeper understanding of these critical arguments.
Keywords: Celiac Disease, Gluten-related disorders, Dietary interventions, Microbiota, Biomarkers, Gluten, Gluten free-diet
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.